Commitments and Contingencies (Details Narrative)
|
|
1 Months Ended |
3 Months Ended |
|
Nov. 03, 2020 |
Feb. 27, 2023
USD ($)
|
Oct. 19, 2019 |
Mar. 31, 2023
USD ($)
shares
|
Mar. 31, 2023
EUR (€)
|
Mar. 31, 2022
USD ($)
|
Mar. 31, 2023
EUR (€)
shares
|
| Stock option granted shares | shares |
|
|
|
1,000,000
|
|
|
1,000,000
|
| Restricted stock option granted shares | shares |
|
|
|
500,000
|
|
|
500,000
|
| Payments For Future Research And Collobration |
|
|
|
$ 959,406
|
|
|
|
| Aggerate Amount Payable, Description |
under the agreement will be completed by the end of the third quarter 2023 at a total cost to the Company of up to $4.2 million
|
|
|
|
|
|
|
| Payable By Company For Services Rendered |
|
|
|
2,173,569
|
|
|
|
| Accrued compensation expense |
|
|
|
726,048
|
|
|
|
| Share-based Payment Arrangement, Noncash Expense |
|
|
|
693,657
|
|
$ 915,031
|
|
| Amount Repayable |
|
|
|
143,550
|
|
|
|
| Long-term debt payable |
|
|
|
3,670,185
|
|
|
|
| Grant Repyable |
|
|
|
468,333
|
|
|
|
| First Insurance Funding |
|
$ 356,258
|
|
|
|
|
|
| Fixed Interest Rate |
|
7.42%
|
|
|
|
|
|
| Maturity Date |
|
November 2023
|
|
|
|
|
|
| Principal balance payable |
|
|
|
316,673
|
|
|
|
| Recognized total compensation expense |
|
|
|
494,485
|
|
|
|
| Performance Based Award [Member] | Vest In 2023 [Member] |
|
|
|
|
|
|
|
| Unrecognized compensation expense |
|
|
|
159,569
|
|
|
|
| Share-based Payment Arrangement, Noncash Expense |
|
|
|
741,841
|
|
|
|
| Performance Based Award [Member] | Vest In 2024 [Member] |
|
|
|
|
|
|
|
| Unrecognized compensation expense |
|
|
|
134,992
|
|
|
|
| Share-based Payment Arrangement, Noncash Expense |
|
|
|
624,429
|
|
|
|
| Restricted Stock Units [Member] |
|
|
|
|
|
|
|
| Recognized total compensation expense |
|
|
|
269,681
|
|
|
|
| RSU Vested in 2023 |
|
|
|
130,908
|
|
|
|
| RSU Vested in 2025 |
|
|
|
93,896
|
|
|
|
| Unrecognized compensation expense |
|
|
|
1,159,695
|
|
|
|
| Managing Director's Agreement [Member] |
|
|
|
|
|
|
|
| Amount payable |
|
|
|
212
|
|
|
|
| Royalty Payment |
|
|
|
$ 119,595
|
|
|
|
| Royality |
|
|
|
6.00%
|
6.00%
|
|
|
| In 2018 [Member] | Tamu [Member] |
|
|
|
|
|
|
|
| Debt conversion, Converted instrument, Rate |
|
|
7.50%
|
|
|
|
|
| Additional interest |
|
|
5.00%
|
|
|
|
|
| Equity Interest |
|
|
12.50%
|
|
|
|
|
| Equity interest in Volition Vet |
|
|
|
12.50%
|
12.50%
|
|
|
| 2022 [Member] | Loan Agreement [Member] | Long-term Debt [Member] | First Insurance Funding [Member] |
|
|
|
|
|
|
|
| Loan Agreement Term |
|
|
|
4 years
|
4 years
|
|
|
| Repayment Of Long-term Loan Amount |
|
|
|
$ 1,000,000.0
|
|
|
|
| Fixed Interest Rate |
|
|
|
6.00%
|
|
|
6.00%
|
| Maturity Date |
|
|
|
July 2026
|
July 2026
|
|
|
| Principal Balance Payable |
|
|
|
$ 1,040,458
|
|
|
|
| On September 16, 2020 [Member] | Bioinformatic Analytics Of Cell Free DNA [Member] |
|
|
|
|
|
|
|
| Repayment Of Long-term Loan Amount | € |
|
|
|
|
€ 54,879
|
|
|
| Total Long-term Debt |
|
|
|
117,711
|
|
|
|
| Additional Cost Of Company |
|
|
|
40,918
|
|
|
|
| Collaborative Obligations Amount Due |
|
|
|
0
|
|
|
|
| Two Thousand Twenty Two [Member] | Univercity Of Texas MD [Member] |
|
|
|
|
|
|
|
| Additional Cost Of Company |
|
|
|
449,406
|
|
|
|
| Collaborative Obligations Amount Due |
|
|
|
$ 449,406
|
|
|
|
| October 31 2022 [Member] |
|
|
|
|
|
|
|
| Restricted stock option granted shares | shares |
|
|
|
1,144,000
|
|
|
1,144,000
|
| October 31 2022 One [Member] |
|
|
|
|
|
|
|
| Restricted stock option granted shares | shares |
|
|
|
450,000
|
|
|
450,000
|
| Walloon Region Government [Member] | In 2018 [Member] | Colorectal Cancer Research Agreement [Member] |
|
|
|
|
|
|
|
| Repayment Of Grants | € |
|
|
|
|
|
|
€ 181,500
|
| Terms Of Agreement Description |
|
|
|
it is due to pay a 3.53% royalty on such revenue to the Walloon Region. The maximum amount payable to the Walloon Region, in respect of the aggregate of the amount repayable of €181,500 and the 3.53% royalty on revenue, is equal to the amount of funding received
|
it is due to pay a 3.53% royalty on such revenue to the Walloon Region. The maximum amount payable to the Walloon Region, in respect of the aggregate of the amount repayable of €181,500 and the 3.53% royalty on revenue, is equal to the amount of funding received
|
|
|
| Amount Repayable |
|
|
|
$ 108,678
|
|
|
|
| Grant Receivable | € |
|
|
|
|
|
|
605,000
|
| Grant Repaid By Installments |
|
|
|
over 12 years
|
over 12 years
|
|
|
| Walloon Region Government [Member] | In 2020 [Member] |
|
|
|
|
|
|
|
| Repayment Of Grants | € |
|
|
|
|
|
|
278,830
|
| Terms Of Agreement Description |
|
|
|
it is due to pay a 2.89% royalty on such revenue to the Walloon Region. The maximum amount payable to the Walloon Region, in respect of the aggregate of the amount repayable of €148,500 and the 2.89% royalty on revenue, is equal to the amount of funding received
|
it is due to pay a 2.89% royalty on such revenue to the Walloon Region. The maximum amount payable to the Walloon Region, in respect of the aggregate of the amount repayable of €148,500 and the 2.89% royalty on revenue, is equal to the amount of funding received
|
|
|
| Amount Repayable |
|
|
|
$ 233,401
|
|
|
|
| Grant Receivable | € |
|
|
|
|
|
|
929,433
|
| Grant Repaid By Installments |
|
|
|
over 15 years
|
over 15 years
|
|
|
| Walloon Region Government [Member] | In 2020 [Member] | Colorectal Cancer Research Agreement [Member] |
|
|
|
|
|
|
|
| Repayment Of Grants | € |
|
|
|
|
|
|
148,500
|
| Terms Of Agreement Description |
|
|
|
it is due to pay a 4.34% royalty on such revenue to the Walloon Region. The maximum amount payable to the Walloon Region, in respect of the aggregate of the amount repayable of €278,830 and the 4.34% royalty on revenue, is equal to the amount of funding received
|
it is due to pay a 4.34% royalty on such revenue to the Walloon Region. The maximum amount payable to the Walloon Region, in respect of the aggregate of the amount repayable of €278,830 and the 4.34% royalty on revenue, is equal to the amount of funding received
|
|
|
| Amount Repayable |
|
|
|
$ 99,073
|
|
|
|
| Grant Receivable | € |
|
|
|
|
|
|
495,000
|
| Grant Repaid By Installments |
|
|
|
over 10 years
|
over 10 years
|
|
|
| Walloon Region Government [Member] | In 2010 [Member] |
|
|
|
|
|
|
|
| Repayment Of Grants | € |
|
|
|
|
|
|
314,406
|
| Terms Of Agreement Description |
|
|
|
it is due to pay a 6% royalty on such revenue to the Walloon Region. The maximum amount payable to the Walloon Region, in respect of the aggregate of the amount repayable of €314,406 and the 6.00% royalty on revenue, is equal to twice the amount of funding received
|
it is due to pay a 6% royalty on such revenue to the Walloon Region. The maximum amount payable to the Walloon Region, in respect of the aggregate of the amount repayable of €314,406 and the 6.00% royalty on revenue, is equal to twice the amount of funding received
|
|
|
| Amount Repayable |
|
|
|
$ 27,181
|
|
|
|
| Grant Receivable | € |
|
|
|
|
|
|
€ 1,050,000.00
|
| ING [Member] | In 2016 [Member] | Long-term Debt [Member] |
|
|
|
|
|
|
|
| Maturity Date |
|
|
|
May 2031
|
May 2031
|
|
|
| Fixed Interest Rate On Lease |
|
|
|
2.62%
|
|
|
2.62%
|
| Lease Payable |
|
|
|
$ 476,894
|
|
|
|
| ING [Member] | In 2016 [Member] | Loan Agreement [Member] | Long-term Debt [Member] |
|
|
|
|
|
|
|
| Loan Agreement Term |
|
|
|
15 years
|
15 years
|
|
|
| Repayment Of Long-term Loan Amount | € |
|
|
|
|
€ 270,000
|
|
|
| Fixed Interest Rate |
|
|
|
2.62%
|
|
|
2.62%
|
| Maturity Date |
|
|
|
December 2031
|
December 2031
|
|
|
| Principal Balance Payable |
|
|
|
$ 186,606
|
|
|
|
| Namur Invest [Member] | In 2016 [Member] | Loan Agreement [Member] | Long-term Debt [Member] |
|
|
|
|
|
|
|
| Loan Agreement Term |
|
|
|
7 years
|
7 years
|
|
|
| Repayment Of Long-term Loan Amount | € |
|
|
|
|
€ 440,000
|
|
|
| Fixed Interest Rate |
|
|
|
4.85%
|
|
|
4.85%
|
| Maturity Date |
|
|
|
December 2023
|
December 2023
|
|
|
| Total Long-term Debt |
|
|
|
$ 63,182
|
|
|
|
| Namur Invest [Member] | In 2019 [Member] | Loan Agreement [Member] | Long-term Debt [Member] |
|
|
|
|
|
|
|
| Loan Agreement Term |
|
|
|
4 years
|
4 years
|
|
|
| Repayment Of Long-term Loan Amount | € |
|
|
|
|
€ 500,000
|
|
|
| Fixed Interest Rate |
|
|
|
4.80%
|
|
|
4.80%
|
| Maturity Date |
|
|
|
September 2024
|
September 2024
|
|
|
| Total Long-term Debt |
|
|
|
$ 244,177
|
|
|
|
| Namur Invest [Member] | In 2020 [Member] | Loan Agreement [Member] | Long-term Debt [Member] |
|
|
|
|
|
|
|
| Loan Agreement Term |
|
|
|
10 years
|
10 years
|
|
|
| Repayment Of Long-term Loan Amount | € |
|
|
|
|
€ 830,000
|
|
|
| Fixed Interest Rate |
|
|
|
4.00%
|
|
|
4.00%
|
| Maturity Date |
|
|
|
March 2031
|
March 2031
|
|
|
| Principal Balance Payable |
|
|
|
$ 749,543
|
|
|
|
| SOFINEX [Member] | In 2017 [Member] | Loan Agreement [Member] | Long-term Debt [Member] |
|
|
|
|
|
|
|
| Loan Agreement Term |
|
|
|
7 years
|
7 years
|
|
|
| Fixed Interest Rate |
|
|
|
4.50%
|
|
|
4.50%
|
| Maturity Date |
|
|
|
September 2024
|
September 2024
|
|
|
| Total Long-term Debt |
|
|
|
$ 434,892
|
|
|
|
| Namur [Member] | 2022 [Member] | Loan Agreement [Member] | Long-term Debt [Member] |
|
|
|
|
|
|
|
| Loan Agreement Term |
|
|
|
4 years
|
4 years
|
|
|
| Repayment Of Long-term Loan Amount | € |
|
|
|
|
€ 500,000
|
|
|
| Fixed Interest Rate |
|
|
|
5.45%
|
|
|
5.45%
|
| Maturity Date |
|
|
|
December 2027
|
December 2027
|
|
|
| Principal Balance Payable |
|
|
|
$ 543,615
|
|
|
|
| University of Taiwan [Member] | In 2018 [Member] | Clinical Study Research Agreement [Member] |
|
|
|
|
|
|
|
| Collaborative Obligations Amount Due |
|
|
|
510,000
|
|
|
|
| Collaborative Obligations Amount |
|
|
|
$ 2,550,000
|
|
|
|
| Lease Agreement Expire Period |
|
|
|
3 years
|
3 years
|
|
|
| Operating Lease Right of Use Obligations [Member] |
|
|
|
|
|
|
|
| Operating Lease Right-of-use Assets |
|
|
|
$ 593,114
|
|
|
|
| Operating Lease Liabilities |
|
|
|
$ 620,486
|
|
|
|
| Weighted Average Discount Rate |
|
|
|
2.56%
|
|
|
2.56%
|
| Payment Of Lease Liabilities |
|
|
|
$ 62,042
|
|
|
|
| Operating Lease Expense |
|
|
|
62,877
|
|
|
|
| Short Term Lease Costs |
|
|
|
$ 16,458
|
|
|
|
| Namur Innovation and Growth [Member] | In 2021 [Member] | Loan Agreement [Member] | Long-term Debt [Member] |
|
|
|
|
|
|
|
| Loan Agreement Term |
|
|
|
3 years 5 months 30 days
|
3 years 5 months 30 days
|
|
|
| Repayment Of Long-term Loan Amount | € |
|
|
|
|
€ 450,000
|
|
|
| Fixed Interest Rate |
|
|
|
5.00%
|
|
|
5.00%
|
| Maturity Date |
|
|
|
June 2025
|
June 2025
|
|
|
| Total Long-term Debt |
|
|
|
$ 407,712
|
|
|
|